Clinical trials
Completed Phase 1 Metabolic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 34 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 6 |
| Chong Kun Dang Pharmaceutical | 3 |
| AO GENERIUM | 2 |
| Eli Lilly and Company | 2 |
| Merck Sharp & Dohme LLC | 2 |
| AstraZeneca | 1 |
| Beta-Stim Ltd. | 1 |
| CRISPR Therapeutics AG | 1 |
| Carmot Therapeutics, Inc. | 1 |
| Corbus Pharmaceuticals Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 34 |
| Diabetes Mellitus, Type 2 | 10 |
| Diabetes Mellitus | 9 |
| Glucose Metabolism Disorders | 9 |
| Endocrine System Diseases | 8 |
| Lipid Metabolism Disorders | 6 |
| Obesity | 6 |
| Dyslipidemias | 5 |
| Hyperlipidemias | 5 |
| Overweight | 4 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.